Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Ghrelin: A link between ageing, metabolism and neurodegenerative disorders.
Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.
SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
Congenic mapping confirms a locus on rat chromosome 10 conferring strong protection against myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
CSF1R-related leukoencephalopathy mimicking primary progressive multiple sclerosis.
Interferon β associated nephropathy in a Multiple Sclerosis patient: A case and review.
Peripheral neuropathies.
Deletion of 14-3-3σ sensitizes mice to DMBA/TPA-induced papillomatosis.
Emergency Department MRI Scanning of Patients with Multiple Sclerosis: Worthwhile or Wasteful?
Data quality evaluation for observational multiple sclerosis registries.
Experimental autoimmune encephalomyelitis (EAE): lesion visualization on a 3 Tesla clinical whole-body system after intraperitoneal contrast injection.
Vitamin D Intake and its Protective Role in Multiple Sclerosis: The Checkmate to Survivin?
Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis.
Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.
The effects of thrombomodulin and activated protein C on the pathogenesis of multiple sclerosis.
Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.
ROCK inhibition enhances neurite outgrowth in neural stem cells by upregulating YAP expression in vitro.
Multiple sclerosis activated by anti-tumor necrosis factor α (Etanercept) and the genetic risk.
N-Truncated Aβ 2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.
IL-3 promotes the development of experimental autoimmune encephalitis.
Functional Brain Network Alterations in Clinically Isolated Syndrome and Multiple Sclerosis: A Graph-based Connectome Study.
Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.
HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Pages
« first
‹ previous
…
736
737
738
739
740
741
742
743
744
…
next ›
last »